ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paclitaxel Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-5J4435
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Paclitaxel Injection Market Research Report 2021
BUY CHAPTERS

Global Paclitaxel Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-5J4435
Report
May 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Paclitaxel Injection Market Size

In 2024, the global market size of Paclitaxel Injection was estimated to be worth US$ 4170 million and is forecast to reach approximately US$ 8626 million by 2031 with a CAGR of 11.1% during the forecast period 2025-2031.

Paclitaxel Injection Market

Paclitaxel Injection Market

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi"s sarcoma, it may be given once every 2 or 3 weeks.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Paclitaxel Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Injection.
The Paclitaxel Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Paclitaxel Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Paclitaxel Injection Market Report

Report Metric Details
Report Name Paclitaxel Injection Market
CAGR 11.1%
Segment by Type
  • 5ml,30mg
  • 10ml,60mg
  • 16.7ml,100mg
  • 25ml,150mg
  • 50ml,300mg
Segment by Application
  • Ovarian Cancer
  • Breast Cancer
  • Cervical Cancer
  • Pancreatic Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Paclitaxel Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paclitaxel Injection sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Paclitaxel Injection Market?

Ans: Global top five players hold a share about 80%.

What is the Paclitaxel Injection Market share by type?

Ans: In terms of product, 5ml,30mg is the largest segment, with a share about 75%.

Who are the main players in the Paclitaxel Injection Market report?

Ans: The main players in the Paclitaxel Injection Market are Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch

What are the Application segmentation covered in the Paclitaxel Injection Market report?

Ans: The Applications covered in the Paclitaxel Injection Market report are Ovarian Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Other

What are the Type segmentation covered in the Paclitaxel Injection Market report?

Ans: The Types covered in the Paclitaxel Injection Market report are 5ml,30mg, 10ml,60mg, 16.7ml,100mg, 25ml,150mg, 50ml,300mg

1 Study Coverage
1.1 Paclitaxel Injection Product Introduction
1.2 Market by Type
1.2.1 Global Paclitaxel Injection Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Market by Application
1.3.1 Global Paclitaxel Injection Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Paclitaxel Injection Market Size Estimates and Forecasts
2.1.1 Global Paclitaxel Injection Revenue 2020-2031
2.1.2 Global Paclitaxel Injection Sales 2020-2031
2.2 Paclitaxel Injection Market Size by Region: 2024 Versus 2031
2.3 Paclitaxel Injection Sales by Region (2020-2031)
2.3.1 Global Paclitaxel Injection Sales by Region: 2020-2025
2.3.2 Global Paclitaxel Injection Sales Forecast by Region (2026-2031)
2.3.3 Global Paclitaxel Injection Sales Market Share by Region (2020-2031)
2.4 Paclitaxel Injection Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Paclitaxel Injection Revenue by Region: 2020-2025
2.4.2 Global Paclitaxel Injection Revenue Forecast by Region (2026-2031)
2.4.3 Global Paclitaxel Injection Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Paclitaxel Injection Sales by Type (2020-2031)
3.1.1.1 Global Paclitaxel Injection Sales Volume by Type (2020-2031)
3.1.1.2 Global Paclitaxel Injection Sales Market Share by Type (2020-2031)
3.1.2 Global Paclitaxel Injection Revenue by Type (2020-2031)
3.1.2.1 Global Paclitaxel Injection Revenue by Type (2020-2031)
3.1.2.2 Global Paclitaxel Injection Revenue Market Share by Type (2020-2031)
3.1.3 Paclitaxel Injection Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Paclitaxel Injection Sales by Application (2020-2031)
3.2.1.1 Global Paclitaxel Injection Sales Volume by Application (2020-2031)
3.2.1.2 Global Paclitaxel Injection Sales Market Share by Application (2020-2031)
3.2.2 Global Paclitaxel Injection Revenue by Application (2020-2031)
3.2.2.1 Global Paclitaxel Injection Revenue by Application (2020-2031)
3.2.2.2 Global Paclitaxel Injection Revenue Market Share by Application (2020-2031)
3.2.3 Paclitaxel Injection Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 5ml,30mg of Paclitaxel Injection Revenue Market Share by Application
3.3.2 10ml,60mg of Paclitaxel Injection Revenue Market Share by Application
3.3.3 16.7ml,100mg of Paclitaxel Injection Revenue Market Share by Application
3.3.4 25ml,150mg of Paclitaxel Injection Revenue Market Share by Application
3.3.5 50ml,300mg of Paclitaxel Injection Revenue Market Share by Application
4 Global Paclitaxel Injection by Manufacturers
4.1 Global Top Paclitaxel Injection Manufacturers by Sales (2020-2025)
4.1.1 Global Paclitaxel Injection Sales by Manufacturer (2020-2025)
4.1.2 Global Paclitaxel Injection Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Paclitaxel Injection Manufacturers by Revenue (2020-2025)
4.2.1 Global Paclitaxel Injection Revenue by Manufacturer (2020-2025)
4.2.2 Global Paclitaxel Injection Revenue Share by Manufacturer (2020-2025)
4.3 Global Paclitaxel Injection Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Paclitaxel Injection Manufacturers Covered: Ranking by Revenue
4.4.2 Global Paclitaxel Injection Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Paclitaxel Injection Manufacturing Base Distribution, Product Type
4.5.1 Paclitaxel Injection Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Paclitaxel Injection Market
4.5.3 Manufacturers Paclitaxel Injection Product Type and Application
4.5.4 5ml,30mg Market Sales of Paclitaxel Injection by Manufacturer
4.5.5 10ml,60mg Market Sales of Paclitaxel Injection by Manufacturer
4.5.6 16.7ml,100mg Market Sales of Paclitaxel Injection by Manufacturer
4.5.7 25ml,150mg Market Sales of Paclitaxel Injection by Manufacturer
4.5.8 50ml,300mg Market Sales of Paclitaxel Injection by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bristol-Myers Squibb
5.1.1 Bristol-Myers Squibb Company Information
5.1.2 Bristol-Myers Squibb Description, Business Overview
5.1.3 Bristol-Myers Squibb Paclitaxel Injection Products Offered
5.1.4 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Bristol-Myers Squibb Paclitaxel Injection Sales by Product in 2024
5.1.6 Bristol-Myers Squibb Paclitaxel Injection Sales by Application in 2024
5.1.7 Bristol-Myers Squibb Paclitaxel Injection Sales by Geographic Area in 2024
5.1.8 Bristol-Myers Squibb Recent Developments
5.2 Celgene Corporation
5.2.1 Celgene Corporation Company Information
5.2.2 Celgene Corporation Description, Business Overview
5.2.3 Celgene Corporation Paclitaxel Injection Products Offered
5.2.4 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Celgene Corporation Paclitaxel Injection Sales by Product in 2024
5.2.6 Celgene Corporation Paclitaxel Injection Sales by Application in 2024
5.2.7 Celgene Corporation Paclitaxel Injection Sales by Geographic Area in 2024
5.2.8 Celgene Corporation Recent Developments
5.3 Hospira
5.3.1 Hospira Company Information
5.3.2 Hospira Description, Business Overview
5.3.3 Hospira Paclitaxel Injection Products Offered
5.3.4 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Hospira Paclitaxel Injection Sales by Product in 2024
5.3.6 Hospira Paclitaxel Injection Sales by Application in 2024
5.3.7 Hospira Paclitaxel Injection Sales by Geographic Area in 2024
5.3.8 Hospira Recent Developments
5.4 Biological E.
5.4.1 Biological E. Company Information
5.4.2 Biological E. Description, Business Overview
5.4.3 Biological E. Paclitaxel Injection Products Offered
5.4.4 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Biological E. Paclitaxel Injection Sales by Product in 2024
5.4.6 Biological E. Paclitaxel Injection Sales by Application in 2024
5.4.7 Biological E. Paclitaxel Injection Sales by Geographic Area in 2024
5.4.8 Biological E. Recent Developments
5.5 Taj Accura
5.5.1 Taj Accura Company Information
5.5.2 Taj Accura Description, Business Overview
5.5.3 Taj Accura Paclitaxel Injection Products Offered
5.5.4 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Taj Accura Paclitaxel Injection Sales by Product in 2024
5.5.6 Taj Accura Paclitaxel Injection Sales by Application in 2024
5.5.7 Taj Accura Paclitaxel Injection Sales by Geographic Area in 2024
5.5.8 Taj Accura Recent Developments
5.6 Khandelwal Laboratories
5.6.1 Khandelwal Laboratories Company Information
5.6.2 Khandelwal Laboratories Description, Business Overview
5.6.3 Khandelwal Laboratories Paclitaxel Injection Products Offered
5.6.4 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Khandelwal Laboratories Paclitaxel Injection Sales by Product in 2024
5.6.6 Khandelwal Laboratories Paclitaxel Injection Sales by Application in 2024
5.6.7 Khandelwal Laboratories Paclitaxel Injection Sales by Geographic Area in 2024
5.6.8 Khandelwal Laboratories Recent Developments
5.7 Luye Pharma
5.7.1 Luye Pharma Company Information
5.7.2 Luye Pharma Description, Business Overview
5.7.3 Luye Pharma Paclitaxel Injection Products Offered
5.7.4 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Luye Pharma Paclitaxel Injection Sales by Product in 2024
5.7.6 Luye Pharma Paclitaxel Injection Sales by Application in 2024
5.7.7 Luye Pharma Paclitaxel Injection Sales by Geographic Area in 2024
5.7.8 Luye Pharma Recent Developments
5.8 Beijing Youcare
5.8.1 Beijing Youcare Company Information
5.8.2 Beijing Youcare Description, Business Overview
5.8.3 Beijing Youcare Paclitaxel Injection Products Offered
5.8.4 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Beijing Youcare Paclitaxel Injection Sales by Product in 2024
5.8.6 Beijing Youcare Paclitaxel Injection Sales by Application in 2024
5.8.7 Beijing Youcare Paclitaxel Injection Sales by Geographic Area in 2024
5.8.8 Beijing Youcare Recent Developments
5.9 Beijing Union
5.9.1 Beijing Union Company Information
5.9.2 Beijing Union Description, Business Overview
5.9.3 Beijing Union Paclitaxel Injection Products Offered
5.9.4 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Beijing Union Paclitaxel Injection Sales by Product in 2024
5.9.6 Beijing Union Paclitaxel Injection Sales by Application in 2024
5.9.7 Beijing Union Paclitaxel Injection Sales by Geographic Area in 2024
5.9.8 Beijing Union Recent Developments
5.10 Haiyao
5.10.1 Haiyao Company Information
5.10.2 Haiyao Description, Business Overview
5.10.3 Haiyao Paclitaxel Injection Products Offered
5.10.4 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Haiyao Paclitaxel Injection Sales by Product in 2024
5.10.6 Haiyao Paclitaxel Injection Sales by Application in 2024
5.10.7 Haiyao Paclitaxel Injection Sales by Geographic Area in 2024
5.10.8 Haiyao Recent Developments
5.11 Chuntch
5.11.1 Chuntch Company Information
5.11.2 Chuntch Description, Business Overview
5.11.3 Chuntch Paclitaxel Injection Products Offered
5.11.4 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Chuntch Paclitaxel Injection Sales by Product in 2024
5.11.6 Chuntch Paclitaxel Injection Sales by Application in 2024
5.11.7 Chuntch Paclitaxel Injection Sales by Geographic Area in 2024
5.11.8 Chuntch Recent Developments
6 North America
6.1 North America Paclitaxel Injection Market Size YoY Growth 2020-2031
6.2 North America Paclitaxel Injection Market Facts & Figures by Country
6.2.1 North America Paclitaxel Injection Sales by Country (2020-2031)
6.2.2 North America Paclitaxel Injection Revenue by Country (2020-2031)
6.3 North America Paclitaxel Injection Sales by Type (2020-2025)
6.4 North America Paclitaxel Injection Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Paclitaxel Injection Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Paclitaxel Injection Market Facts & Figures by Region
7.2.1 Asia-Pacific Paclitaxel Injection Sales by Region (2020-2031)
7.2.2 Asia-Pacific Paclitaxel Injection Revenue by Region (2020-2031)
7.3 Asia-Pacific Paclitaxel Injection Sales by Type (2020-2025)
7.4 Asia-Pacific Paclitaxel Injection Sales by Application (2020-2025)
8 Europe
8.1 Europe Paclitaxel Injection Market Size YoY Growth 2020-2031
8.2 Europe Paclitaxel Injection Market Facts & Figures by Country
8.2.1 Europe Paclitaxel Injection Sales by Country (2020-2031)
8.2.2 Europe Paclitaxel Injection Revenue by Country (2020-2031)
8.3 Europe Paclitaxel Injection Sales by Type (2020-2025)
8.4 Europe Paclitaxel Injection Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Paclitaxel Injection Market Size YoY Growth 2020-2031
9.2 Latin America Paclitaxel Injection Market Facts & Figures by Country
9.2.1 Latin America Paclitaxel Injection Sales by Country (2020-2031)
9.2.2 Latin America Paclitaxel Injection Revenue by Country (2020-2031)
9.3 Latin America Paclitaxel Injection Sales by Type (2020-2025)
9.4 Latin America Paclitaxel Injection Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Paclitaxel Injection Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Paclitaxel Injection Market Facts & Figures by Country
10.2.1 Middle East and Africa Paclitaxel Injection Sales by Country (2020-2031)
10.2.2 Middle East and Africa Paclitaxel Injection Revenue by Country (2020-2031)
10.3 Middle East and Africa Paclitaxel Injection Sales by Type (2020-2025)
10.4 Middle East and Africa Paclitaxel Injection Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Paclitaxel Injection Supply Chain Analysis
11.2 Paclitaxel Injection Key Raw Materials and Upstream Suppliers
11.3 Paclitaxel Injection Clients Analysis
11.4 Paclitaxel Injection Sales Channel and Sales Model Analysis
11.4.1 Paclitaxel Injection Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Paclitaxel Injection Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Paclitaxel Injection Distributors
12 Paclitaxel Injection Market Dynamics
12.1 Paclitaxel Injection Industry Trends
12.2 Paclitaxel Injection Market Drivers
12.3 Paclitaxel Injection Market Challenges
12.4 Paclitaxel Injection Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
List of Tables
 Table 1. Global Paclitaxel Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Paclitaxel Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Paclitaxel Injection Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Paclitaxel Injection Sales by Region (2020-2025) & (K Units)
 Table 5. Global Paclitaxel Injection Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Paclitaxel Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Paclitaxel Injection Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Paclitaxel Injection Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Paclitaxel Injection Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Paclitaxel Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Paclitaxel Injection Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Paclitaxel Injection Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Paclitaxel Injection Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Paclitaxel Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Paclitaxel Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Paclitaxel Injection Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Paclitaxel Injection Sales Share by Manufacturer (2020-2025)
 Table 18. Paclitaxel Injection Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Paclitaxel Injection Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Paclitaxel Injection Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Paclitaxel Injection Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Paclitaxel Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2024)
 Table 24. Paclitaxel Injection Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Paclitaxel Injection Market
 Table 26. Manufacturers Paclitaxel Injection Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Bristol-Myers Squibb Company Information
 Table 29. Bristol-Myers Squibb Description and Business Overview
 Table 30. Bristol-Myers Squibb Paclitaxel Injection Product
 Table 31. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Bristol-Myers Squibb Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 33. Bristol-Myers Squibb Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 34. Bristol-Myers Squibb Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 35. Bristol-Myers Squibb Recent Developments
 Table 36. Celgene Corporation Company Information
 Table 37. Celgene Corporation Description and Business Overview
 Table 38. Celgene Corporation Paclitaxel Injection Product
 Table 39. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Celgene Corporation Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 41. Celgene Corporation Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 42. Celgene Corporation Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 43. Celgene Corporation Recent Developments
 Table 44. Hospira Company Information
 Table 45. Hospira Description and Business Overview
 Table 46. Hospira Paclitaxel Injection Product
 Table 47. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Hospira Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 49. Hospira Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 50. Hospira Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 51. Hospira Recent Developments
 Table 52. Biological E. Company Information
 Table 53. Biological E. Description and Business Overview
 Table 54. Biological E. Paclitaxel Injection Product
 Table 55. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Biological E. Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 57. Biological E. Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 58. Biological E. Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 59. Biological E. Recent Developments
 Table 60. Taj Accura Company Information
 Table 61. Taj Accura Description and Business Overview
 Table 62. Taj Accura Paclitaxel Injection Product
 Table 63. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Taj Accura Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 65. Taj Accura Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 66. Taj Accura Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 67. Taj Accura Recent Developments
 Table 68. Khandelwal Laboratories Company Information
 Table 69. Khandelwal Laboratories Description and Business Overview
 Table 70. Khandelwal Laboratories Paclitaxel Injection Product
 Table 71. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Khandelwal Laboratories Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 73. Khandelwal Laboratories Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 74. Khandelwal Laboratories Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 75. Khandelwal Laboratories Recent Developments
 Table 76. Luye Pharma Company Information
 Table 77. Luye Pharma Description and Business Overview
 Table 78. Luye Pharma Paclitaxel Injection Product
 Table 79. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Luye Pharma Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 81. Luye Pharma Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 82. Luye Pharma Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 83. Luye Pharma Recent Developments
 Table 84. Beijing Youcare Company Information
 Table 85. Beijing Youcare Description and Business Overview
 Table 86. Beijing Youcare Paclitaxel Injection Product
 Table 87. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Beijing Youcare Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 89. Beijing Youcare Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 90. Beijing Youcare Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 91. Beijing Youcare Recent Developments
 Table 92. Beijing Union Company Information
 Table 93. Beijing Union Description and Business Overview
 Table 94. Beijing Union Paclitaxel Injection Product
 Table 95. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Beijing Union Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 97. Beijing Union Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 98. Beijing Union Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 99. Beijing Union Recent Developments
 Table 100. Haiyao Company Information
 Table 101. Haiyao Description and Business Overview
 Table 102. Haiyao Paclitaxel Injection Product
 Table 103. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Haiyao Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 105. Haiyao Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 106. Haiyao Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 107. Haiyao Recent Developments
 Table 108. Chuntch Company Information
 Table 109. Chuntch Description and Business Overview
 Table 110. Chuntch Paclitaxel Injection Product
 Table 111. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Chuntch Sales Proportion of Paclitaxel Injection by Product in 2024
 Table 113. Chuntch Sales Proportion of Paclitaxel Injection by Application in 2024
 Table 114. Chuntch Sales Proportion of Paclitaxel Injection by Geographic Area in 2024
 Table 115. Chuntch Recent Developments
 Table 116. North America Paclitaxel Injection Sales by Country (2020-2025) & (K Units)
 Table 117. North America Paclitaxel Injection Sales by Country (2026-2031) & (K Units)
 Table 118. North America Paclitaxel Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Paclitaxel Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Paclitaxel Injection Sales by Type (2020-2025) & (K Units)
 Table 121. North America Paclitaxel Injection Sales by Application (2020-2025) & (K Units)
 Table 122. Asia-Pacific Paclitaxel Injection Sales by Region (2020-2025) & (K Units)
 Table 123. Asia-Pacific Paclitaxel Injection Sales by Region (2026-2031) & (K Units)
 Table 124. Asia-Pacific Paclitaxel Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Paclitaxel Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Paclitaxel Injection Sales by Type (2020-2025) & (K Units)
 Table 127. Asia-Pacific Paclitaxel Injection Sales by Application (2020-2025) & (K Units)
 Table 128. Europe Paclitaxel Injection Sales by Country (2020-2025) & (K Units)
 Table 129. Europe Paclitaxel Injection Sales by Country (2026-2031) & (K Units)
 Table 130. Europe Paclitaxel Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Paclitaxel Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Paclitaxel Injection Sales by Type (2020-2025) & (K Units)
 Table 133. Europe Paclitaxel Injection Sales by Application (2020-2025) & (K Units)
 Table 134. Latin America Paclitaxel Injection Sales by Country (2020-2025) & (K Units)
 Table 135. Latin America Paclitaxel Injection Sales by Country (2026-2031) & (K Units)
 Table 136. Latin America Paclitaxel Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Paclitaxel Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Paclitaxel Injection Sales by Type (2020-2025) & (K Units)
 Table 139. Latin America Paclitaxel Injection Sales by Application (2020-2025) & (K Units)
 Table 140. Middle East and Africa Paclitaxel Injection Sales by Country (2020-2025) & (K Units)
 Table 141. Middle East and Africa Paclitaxel Injection Sales by Country (2026-2031) & (K Units)
 Table 142. Middle East and Africa Paclitaxel Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Paclitaxel Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Paclitaxel Injection Sales by Type (2020-2025) & (K Units)
 Table 145. Middle East and Africa Paclitaxel Injection Sales by Application (2020-2025) & (K Units)
 Table 146. Paclitaxel Injection Key Raw Materials, Industry Status and Trend
 Table 147. Paclitaxel Injection Key Raw Materials and Upstream Suppliers
 Table 148. Paclitaxel Injection Clients Status and Trend
 Table 149. Paclitaxel Injection Typical Clients
 Table 150. Paclitaxel Injection Distributors
 Table 151. Paclitaxel Injection Market Trends
 Table 152. Paclitaxel Injection Market Drivers
 Table 153. Paclitaxel Injection Market Challenges
 Table 154. Paclitaxel Injection Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Paclitaxel Injection Product Picture
 Figure 2. Global Paclitaxel Injection Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Paclitaxel Injection Sales Market Share by Type in 2024 & 2031
 Figure 4. 5ml,30mg Product Picture
 Figure 5. 10ml,60mg Product Picture
 Figure 6. 16.7ml,100mg Product Picture
 Figure 7. 25ml,150mg Product Picture
 Figure 8. 50ml,300mg Product Picture
 Figure 9. Global Paclitaxel Injection Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 10. Global Paclitaxel Injection Sales Market Share by Application in 2024 & 2031
 Figure 11. Ovarian Cancer
 Figure 12. Breast Cancer
 Figure 13. Cervical Cancer
 Figure 14. Pancreatic Cancer
 Figure 15. Other
 Figure 16. Paclitaxel Injection Report Years Considered
 Figure 17. Global Paclitaxel Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Paclitaxel Injection Market Size 2020-2031 (US$ Million)
 Figure 19. Global Paclitaxel Injection Sales 2020-2031 (K Units)
 Figure 20. Global Paclitaxel Injection Sales Market Share Forecast by Region (2020-2031)
 Figure 21. Global Paclitaxel Injection Revenue Market Share by Region (2020-2031)
 Figure 22. Global Paclitaxel Injection Sales Market Share Forecast by Type (2020-2031)
 Figure 23. Global Paclitaxel Injection Revenue Market Share Forecast by Type (2020-2031)
 Figure 24. Paclitaxel Injection Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 25. Global Paclitaxel Injection Sales Market Share Forecast by Application (2020-2031)
 Figure 26. Global Paclitaxel Injection Revenue Market Share Forecast by Application (2020-2031)
 Figure 27. Paclitaxel Injection Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 28. 5ml,30mg of Paclitaxel Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 29. 10ml,60mg of Paclitaxel Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 30. 16.7ml,100mg of Paclitaxel Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 31. 25ml,150mg of Paclitaxel Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 32. 50ml,300mg of Paclitaxel Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 33. Global Paclitaxel Injection Sales Share by Manufacturer in 2024
 Figure 34. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 35. 5ml,30mg Market Sales Proportion by Manufacturer in 2024
 Figure 36. 10ml,60mg Market Sales Proportion by Manufacturer in 2024
 Figure 37. 16.7ml,100mg Market Sales Proportion by Manufacturer in 2024
 Figure 38. 25ml,150mg Market Sales Proportion by Manufacturer in 2024
 Figure 39. 50ml,300mg Market Sales Proportion by Manufacturer in 2024
 Figure 40. North America Paclitaxel Injection Revenue 2020-2031 (US$ Million)
 Figure 41. North America Paclitaxel Injection Sales Market Share by Type (2020-2025)
 Figure 42. North America Paclitaxel Injection Sales Market Share by Application (2020-2025)
 Figure 43. Asia-Pacific Paclitaxel Injection Revenue 2020-2031 (US$ Million)
 Figure 44. Asia-Pacific Paclitaxel Injection Sales Market Share by Region (2020-2031)
 Figure 45. Asia-Pacific Paclitaxel Injection Revenue Market Share by Region (2020-2031)
 Figure 46. Asia-Pacific Paclitaxel Injection Sales Market Share by Type (2020-2025)
 Figure 47. Asia-Pacific Paclitaxel Injection Sales Market Share by Application (2020-2025)
 Figure 48. Europe Paclitaxel Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Europe Paclitaxel Injection Sales Market Share by Country (2020-2031)
 Figure 50. Europe Paclitaxel Injection Revenue Market Share by Country (2020-2031)
 Figure 51. Europe Paclitaxel Injection Sales Market Share by Type (2020-2025)
 Figure 52. Europe Paclitaxel Injection Sales Market Share by Application (2020-2025)
 Figure 53. Latin America Paclitaxel Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Latin America Paclitaxel Injection Sales Market Share by Country (2020-2031)
 Figure 55. Latin America Paclitaxel Injection Revenue Market Share by Country (2020-2025)
 Figure 56. Latin America Paclitaxel Injection Sales Market Share by Type (2020-2025)
 Figure 57. Latin America Paclitaxel Injection Sales Market Share by Application (2020-2025)
 Figure 58. Middle East and Africa Paclitaxel Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 59. Middle East and Africa Paclitaxel Injection Sales Market Share by Country (2020-2031)
 Figure 60. Middle East and Africa Paclitaxel Injection Revenue Market Share by Country (2020-2031)
 Figure 61. Middle East and Africa Paclitaxel Injection Sales Market Share by Type (2020-2025)
 Figure 62. Middle East and Africa Paclitaxel Injection Sales Market Share by Application (2020-2025)
 Figure 63. Paclitaxel Injection Supply Chain (Upstream and Downstream Market)
 Figure 64. Global Production Market Share of Paclitaxel Injection Raw Materials by Region in 2024
 Figure 65. Paclitaxel Injection Distribution Channels
 Figure 66. Global Paclitaxel Injection Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 67. Global Paclitaxel Injection Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Natural Paclitaxel Market Research Report 2024
Global Paclitaxel and Docetaxel APIs Market Research Report 2024
Global Taxol Market Research Report 2024
Global Bulk Paclitaxel Market Research Report 2025
Paclitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paclitaxel Polymer Micelles For Injection Market Research Report 2025
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Research Report 2024
Global Paclitaxel Market Insights Forecast to 2030
Global Cabazitaxel Injection Market Research Report 2024
Global Paclitaxel Coated Balloon Catheter Market Research Report 2024
Paclitaxel Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paclitaxel and Docetaxel Market Research Report 2024
Nanoparticle Albumin bound Paclitaxel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paclitaxel eluting Stent Market Insights Forecast to 2030
Global Injectable HIV Treatment Market Research Report 2024
Global Gemcitabine Injection Market Research Report 2024
Global Paclitaxel Polymeric Micelle Market Research Report 2025
Global Docetaxel Injection Market Research Report 2025
Global Topotecan Injection Market Research Report 2024
Global Injectable HIV Medication Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions